Risk of multiple sclerosis in patients with psoriasis receiving anti-IL-17 agents: A case-based review. Tsiogkas SG, Tsimourtou V, Chaidaki K, Dardiotis E, et al. J Dermatol 2024 Feb 12. doi: 10.1111/1346-8138.17143.

Read + Share

Amedeo Smart

Independent Medical Education

Tsiogkas SG, Tsimourtou V, Chaidaki K, Dardiotis E, et al. Risk of multiple sclerosis in patients with psoriasis receiving anti-IL-17 agents: A case-based review. J Dermatol 2024 Feb 12. doi: 10.1111/1346-8138.17143.
PMID: 38345289